13.100
+0,77%
2026-10-19
Fundamental Analysis
50 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +59.8% | -28.9% | 1 / 3 | +6.7% | +12.18 pp | +9.90 pp | +6.4% | 0.90 | 14.29 | 861 | +6,7% | 244 | +64,0% | 14.29 | 18.21 | −21,5% |
| Pts | 8 | 0 | 4 | 0 | 12 | 12 | 0 | 6 | 12 | |||||||
Valuation annotation:Price: 13.100 (close price on 2026-10-19)EPS (TTM): 916,9
Financial charts
1.Revenue & growth
VND bn861Q2/26
1.Revenue & growth
VND bn861Q2/26
2.Profit & growth
VND bn186Q2/26
3.Profit mix (Penman)
VND bn751Q2/26
4.Margins & cost structure
%39.7%Q2/26
5.Returns & cash cycle
% · days7.4%Q2/26
6.Earnings quality & cash
VND bn1.108Q2/26
7.Asset structure
VND bn14.854Q2/26
8.Funding & debt health
VND bn · times14.854Q2/26
9.Revenue backlog
VND bn90,1Q2/26
10.Valuation
times · %14,3×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %496Q2/26
Adjusted EPS growth, latest quarter
59.8%
Average adjusted EPS growth, 3 quarters
-28.9%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26